Ascenta Capital
Ascenta Capital is a biotech-focused late-stage venture fund, co-founded in 2023 by Dr. Evan Rachlin and Dr. Lorence Kim. The fund is focused on concentrated investments in companies developing portfolios of therapeutics based on innovative platform technologies.
We focus on:
+ Multi-asset platforms
+ Companies with PoC
As an operator-led team, our team has partnered with ADARx, Iambic, Odyssey, Cardurion, and OrsoBio to date.
For more information about Ascenta Capital, visit www.ascentacap.com.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}